Hepion Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q4 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Hepion Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q4 2014 to Q3 2024.
  • Hepion Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 144 %, a 347% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 144 +112 +347% Sep 30, 2024
Q2 2024 88.6 +63.5 +253% Jun 30, 2024
Q1 2024 66.7 +43.6 +188% Mar 31, 2024
Q4 2023 48.5 +30.9 +175% Dec 31, 2023
Q3 2023 32.2 +17 +112% Sep 30, 2023
Q2 2023 25.1 +12.2 +94.9% Jun 30, 2023
Q1 2023 23.1 +13.5 +141% Mar 31, 2023
Q4 2022 17.6 +9.4 +115% Dec 31, 2022
Q3 2022 15.2 +6.48 +74.5% Sep 30, 2022
Q2 2022 12.9 +1.92 +17.5% Jun 30, 2022
Q1 2022 9.61 -5.01 -34.3% Mar 31, 2022
Q4 2021 8.19 -20.8 -71.8% Dec 31, 2021
Q3 2021 8.69 -26.7 -75.4% Sep 30, 2021
Q2 2021 10.9 -18.9 -63.3% Jun 30, 2021
Q1 2021 14.6 -14.5 -49.7% Mar 31, 2021
Q4 2020 29 -16 -35.6% Dec 31, 2020
Q3 2020 35.4 -30.5 -46.3% Sep 30, 2020
Q2 2020 29.8 -86.3 -74.3% Jun 30, 2020
Q1 2020 29.1 -501 -94.5% Mar 31, 2020
Q4 2019 45 -312 -87.4% Dec 31, 2019
Q3 2019 65.9 -238 -78.3% Sep 30, 2019
Q2 2019 116 -173 -59.8% Jun 30, 2019
Q1 2019 530 +375 +241% Mar 31, 2019
Q4 2018 357 +138 +62.7% Dec 31, 2018
Q3 2018 304 +94.8 +45.4% Sep 30, 2018
Q2 2018 289 -87.5 -23.3% Jun 30, 2018
Q1 2018 155 -1.05K -87.1% Mar 31, 2018
Q4 2017 220 -495 -69.2% Dec 31, 2017
Q3 2017 209 -546 -72.3% Sep 30, 2017
Q2 2017 376 -58.6 -13.5% Jun 30, 2017
Q1 2017 1.2K +998 +483% Mar 31, 2017
Q4 2016 714 +624 +695% Dec 31, 2016
Q3 2016 755 +711 +1623% Sep 30, 2016
Q2 2016 435 +413 +1932% Jun 30, 2016
Q1 2016 207 +154 +295% Mar 31, 2016
Q4 2015 89.9 +1.48K Dec 31, 2015
Q3 2015 43.8 Sep 30, 2015
Q2 2015 21.4 Jun 30, 2015
Q1 2015 52.3 Mar 31, 2015
Q4 2014 -1.39K Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.